VRTX

VRTX Other Income/Expenses (Net)

$402.90MTTM · USD

Period ending:

VRTX FY Other Income/Expenses (Net)USD
VRTX FY Other Income/Expenses (Net)1990-12-31: $4.10M1991-12-31: $800.00K1992-12-31: $2.00M1993-12-31: $900.00K1994-12-31: $3.60M1995-12-31: $5.50M1996-12-31: $0.001997-12-31: $0.001998-12-31: $0.001999-12-31: $10.30M2000-12-31: -$16.16M2001-12-31: -$2.79M2002-12-31: $28.30M2003-12-31: $67.76M2004-12-31: -$11.44M2005-12-31: -$53.55M2006-12-31: $21.10M2007-12-31: $28.51M2008-12-31: $2.86M2009-12-31: -$28.17M2010-12-31: -$58.55M2011-12-31: -$53.38M2012-12-31: -$59.11M2013-12-31: -$366.11M2014-12-31: -$42.46M2015-12-31: -$90.92M2016-12-31: -$77.30M2017-12-31: -$138.93M2018-12-31: -$34.91M2019-12-31: $197.42M2020-12-31: $260.60M2021-12-31: -$51.70M2022-12-31: -$75.00M2023-12-31: $547.80M2024-12-31: $481.40M2025-12-31: -$117.50M$547.80M-$366.11M
1990-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

VRTX other income/expenses (net) history

Net other income and expenses outside core operations. The available annual fiscal periods series contains 36 observations from Dec 31, 1990 to Dec 31, 2025.

Vertex Pharmaceuticals Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
-117,500,000
481,400,000
547,800,000
-75,000,000
-51,700,000
260,600,000
197,419,000
-34,909,000
-138,932,000
-77,302,000
-90,921,000
-42,463,000
-366,109,000
-59,108,000
-53,375,000
-58,549,000
-28,166,000
2,857,000
28,513,000
21,101,000
-53,545,000
-11,440,000
67,760,000
28,299,000
-2,789,000
-16,164,000
10,300,000
0
0
0
5,500,000
3,600,000
900,000
2,000,000
800,000
4,100,000

Compare other income/expenses (net)

All VRTX financial metrics · VRTX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.